Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B

Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B

Thomas Scior1, Hans-Georg Mack2, José Antonio Guevara García3, Wolfhard Koch41Departamento de Farmacia. Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, Colonia San Manuel, Puebla, Mexico; 2Institut f...

Full description

Bibliographic Details
Main Authors: Thomas Scior, Hans-Georg Mack, José Antonio Guevara García, Wolfhard Koch
Format: Article
Language:English
Published: Dove Medical Press 2008-11-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/antidiabetic-bis-maltolato-oxovanadiumiv-conversion-of-inactive-trans--a2591

Internet

http://www.dovepress.com/antidiabetic-bis-maltolato-oxovanadiumiv-conversion-of-inactive-trans--a2591

Similar Items